| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Departments of Physiology and
Biophysics, and Obstetrics and
Gynecology, College of Medicine,
University of Illinois at the Medical Center,
Chicago, Illinois
Myocrisin, a hyaluronidase inhibitor of low
molecular weight, was tested for antifertility
activity. In addition, the effect of myocrisin on
penetration of the follicle cell layer by spermatozoa was studied. Myocrisin prevented the in
vitro fertilization of capacitated mouse spermatozoa when these were added to intact oocytes.
The inhibitor had no effect on sperm motility at
the concentrations used for the in vitro fertilization tests, and did not inhibit the acrosome
reaction of guinea pig spermatozoa. Myocrisin
also had no effect on human acrosin. Fertility
was not prevented when the myocrisin-treated
spermatozoa were added to oocytes from
which the follicle cell layer had been removed,
showing that sperm hyaluronidase is essential
specifically for sperm penetration through this
ovum investment, at least in the case of the
mouse. Myocrisin is approved for human use
by the FDA and is a compound worth further in
vivo evaluation as a contraceptive.
Key words: myocrisin, hyaluronidase inhibitor, fertilization, contraception, acrosome reaction, acrosin
Submitted on June 14, 1979
Revised on July 31, 1979
Accepted on July 31, 1979
This article has been cited by other articles:
![]() |
K. Chaudhury, A.K. Bhattacharyya, and S.K. Guha Studies on the membrane integrity of human sperm treated with a new injectable male contraceptive Hum. Reprod., August 1, 2004; 19(8): 1826 - 1830. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |